Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06329583 · ClinicalTrials.gov registry record · NA
Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry
A NA study of Dysphagia and Gastroesophageal Reflux, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06329583: Recruiting NA study of Dysphagia and Gastroesophageal Reflux, sponsored by Mayo Clinic.
NCT06329583 is a NA study of Dysphagia and Gastroesophageal Reflux that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 171-participant average among 35 other Dysphagia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06329583, a NA study of Dysphagia and Gastroesophageal Reflux, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine which position, maneuvers or combination thereof generates the highest pressure at the EGJ as assessed by high-resolution esophageal manometry and thus greater or more robust contraction of the diaphragm.
Primary Outcome
Measurement of EGJ- contractile integral and diaphragmatic pressure with each exercise/instruction
Conditions Studied
Interventions
- DIAGNOSTIC_TEST diaphragmatic breathing
Study Locations (1)
Florida
- Mayo Clinic - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-05-10 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What NCT06329583 shows while recruiting
NCT06329583 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 171-participant average among 35 other Dysphagia trials with a reported enrollment target (82% lower).
The record links to 3 conditions, with Dysphagia appearing as the primary indexed condition, and to 1 intervention - of which diaphragmatic breathing is the first listed.
NCT06329583 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06329583 about?
NCT06329583 is a clinical study titled "Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry". The goal of this study is to determine which position, maneuvers or combination thereof generates the highest pressure at the EGJ as assessed by high-resolution esophageal manometry and thus greater or more robust contraction of the diaphragm.
What is the current status of trial NCT06329583?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-05-10. Estimated completion is 2026-03-01.
What conditions does trial NCT06329583 study?
This clinical trial studies the following conditions: Dysphagia, Gastroesophageal Reflux, Esophageal Motility Disorders.
What interventions are being tested in trial NCT06329583?
The interventions under investigation include: diaphragmatic breathing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06329583?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06329583 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06329583's enrollment target sits among peer trials
30 29th of 35 higher than 6 of 35 other Dysphagia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dysphagia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
RECRUITING · NA
-
Effect of Thickened Feeds on Swallow Physiology in Children With Dysphagia
RECRUITING · NA
-
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
RECRUITING · NA
-
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
RECRUITING · NA
-
External Pharyngeal Exerciser and Pharyngeal Phase of Swallowing
RECRUITING · NA
-
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI